GO:0000422 autophagy of mitochondrion: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0000422 (autophagy of mitochondrion, also called mitophagy) is the selective autophagic process that delivers damaged or surplus mitochondria to the vacuole/lysosome for degradation.
• The PINK1-Parkin axis is the best-characterized mitophagy pathway: PINK1 accumulates on depolarized mitochondria and recruits Parkin to ubiquitinate outer-membrane proteins.
• Receptor-mediated mitophagy (BNIP3, BNIP3L/NIX, FUNDC1, FKBP8) provides ubiquitin-independent routes for mitochondrial clearance.
• Mitophagy is essential for mitochondrial quality control, and its failure is linked to Parkinson's disease, cardiovascular disease, liver disease and ageing.
• Mitophagy is regulated by nutrient and stress signaling, including mTOR-dependent suppression and AMPK/ULK1 activation.
• CRISPR knockout, point-mutation, knock-in and overexpression cell models are widely used to dissect mitophagy gene function and to build disease-relevant screening platforms.
Description
GO:0000422, autophagy of mitochondrion (commonly called mitophagy), is the selective autophagic process in which mitochondria are delivered to a vacuole or lysosome and degraded in response to changing cellular conditions. It is a biological_process term in the Gene Ontology and is distinct from general macroautophagy because the cargo is specifically the mitochondrion. Mitophagy was first recognized as a quality-control mechanism that removes damaged mitochondria, but it is now understood to also shape mitochondrial number during development, metabolic transitions and cell-fate decisions. For researchers, GO:0000422 provides a precise annotation target when studying mitochondrial turnover, and it is a central node connecting mitochondrial biology to neurodegeneration, cardiovascular disease, liver disease and ageing. Because mitophagy is genetically tractable and pharmacologically modifiable, it has become a high-value pathway for both mechanistic studies and therapeutic development.
autophagy of mitochondrion At A Glance
| GO ID | GO:0000422 |
|---|---|
| GO term | autophagy of mitochondrion |
| Ontology | biological_process |
| Synonym | mitophagy; mitochondrion degradation; mitochondrion disassembly |
| Major function | Selective delivery of mitochondria to the vacuole/lysosome for degradation under changing cellular conditions |
| Cargo specificity | Mitochondria, including damaged or surplus organelles |
| Key pathways | PINK1-Parkin ubiquitin-dependent mitophagy and receptor-mediated mitophagy (BNIP3, BNIP3L/NIX, FUNDC1, FKBP8) |
| Physiological roles | Mitochondrial quality control, metabolic remodeling, developmental mitochondrial clearance |
| Disease relevance | Parkinson's disease, cardiovascular disease, liver disease, ageing |
What Is GO:0000422?
In this article, autophagy of mitochondrion (GO:0000422) is defined as the autophagic process in which mitochondria are delivered to a type of vacuole and degraded in response to changing cellular conditions. This definition follows the QuickGO entry for GO:0000422 and its synonym mitophagy. The term captures selective cargo recognition, autophagosome or mitophagosome formation around the mitochondrion, and eventual degradation in the vacuole/lysosome.
Why Is autophagy of mitochondrion Important in Cell Biology?
GO:0000422 is important because mitochondrial integrity is central to cellular energy production, redox balance and apoptosis, and mitophagy is the principal route for removing mitochondria that threaten these functions. Defective mitophagy allows damaged mitochondria to accumulate, increasing reactive oxygen species and cell death, which has been implicated in Parkinson's disease, cardiovascular disease, liver disease and ageing. Conversely, excessive or misregulated mitophagy can deplete mitochondria below the threshold needed for survival, so the pathway must be tightly controlled. Understanding GO:0000422 therefore informs both basic mitochondrial biology and the development of therapies that modulate mitochondrial quality control.
• Maintains mitochondrial quality by removing depolarized or damaged organelles.
• Supports metabolic adaptation by adjusting mitochondrial mass during nutrient shifts.
• Clears paternal mitochondria and surplus mitochondria during development.
• Limits oxidative stress and cell death caused by dysfunctional mitochondria.
• Is genetically linked to Parkinson's disease through PINK1 and PRKN.
• Contributes to cardiomyocyte homeostasis and cardiovascular disease progression.
• Is implicated in liver disease pathogenesis and hepatic metabolic regulation.
• Declines with age and is associated with ageing phenotypes.
• Provides a druggable target for small-molecule mitophagy modulators.
• Serves as a model selective-autophagy pathway for studying cargo recognition.
What Happens During autophagy of mitochondrion?
Initiation and cargo recognition
In simple terms: The cell first marks which mitochondria should be destroyed.
Mitophagy begins when damaged or surplus mitochondria are recognized as cargo. In the PINK1-Parkin pathway, loss of mitochondrial membrane potential stabilizes PINK1 on the outer membrane, which recruits Parkin and leads to ubiquitination of outer-membrane proteins. In receptor-mediated mitophagy, outer-membrane receptors such as BNIP3, BNIP3L/NIX, FUNDC1 and FKBP8 bind LC3/GABARAP proteins to flag the organelle for autophagic capture. This cargo-recognition step determines selectivity and is a major point of regulation.
Autophagosome formation around the mitochondrion
In simple terms: A double-membrane bag forms around the marked mitochondrion.
After recognition, the autophagic machinery assembles a phagophore that expands around the mitochondrion to form a mitophagosome. This process requires core autophagy proteins, including ULK1 complex components, ATG proteins and LC3 lipidation, and it is coordinated with mitochondrial fission to isolate the damaged segment. The resulting structure physically separates the mitochondrion from the cytosol before fusion with the degradative compartment.
Fusion with the vacuole/lysosome and degradation
In simple terms: The bag fuses with the cell's recycling compartment and the mitochondrion is broken down.
The mitophagosome fuses with the vacuole in yeast or the lysosome in mammalian cells, delivering the mitochondrion to an acidic compartment where hydrolases degrade it. Degradation products, including amino acids and nucleotides, are recycled back to the cytosol. Mitochondrial DNA is also eliminated during this process, which is important because unreleased mitochondrial DNA can trigger inflammatory signaling.
Basal versus stress-induced mitophagy
In simple terms: Mitophagy can happen at a low level all the time or be boosted by stress.
Mitophagy operates at a basal level to maintain mitochondrial quality, but it can be strongly induced by stressors such as hypoxia, nutrient deprivation, mitochondrial uncoupling and oxidative stress. Stress-induced mitophagy often depends on transcriptional upregulation of receptors like BNIP3 and BNIP3L/NIX, whereas basal mitophagy may use distinct routes. The balance between basal and induced mitophagy influences cell survival and metabolic state.
Key Genes Involved in GO:0000422 autophagy of mitochondrion
The following genes and proteins are central to the molecular machinery, regulation and disease relevance of GO:0000422 (autophagy of mitochondrion).
| Gene | Major Role | Research Relevance |
|---|---|---|
| PINK1 | Serine/threonine kinase that accumulates on depolarized mitochondria and initiates mitophagy | Loss-of-function mutations cause early-onset Parkinson's disease; key KO and point-mutation model |
| PRKN (Parkin) | E3 ubiquitin ligase recruited by PINK1 to ubiquitinate outer-membrane proteins | Mutations linked to Parkinson's disease; widely used in KO and knock-in studies |
| BNIP3 | Outer-membrane receptor that binds LC3/GABARAP to promote mitophagy | Hypoxia-induced mitophagy; overexpression and KO models |
| BNIP3L (NIX) | Receptor required for developmental mitochondrial clearance, including reticulocyte maturation | Knockout models reveal developmental mitophagy defects |
| FUNDC1 | Outer-membrane receptor regulated by phosphorylation to promote mitophagy under hypoxia | Point-mutation studies of phosphorylation sites |
| FKBP8 | Outer-membrane protein that recruits LC3A to mitochondria independently of Parkin | Alternative mitophagy route; KO and tagged knock-in models |
| ULK1 | Kinase in the autophagy initiation complex activated by AMPK | Central regulator; KO and point-mutation models |
| ATG5 | Core autophagy protein required for LC3 lipidation and autophagosome formation | Essential for mitophagy; conditional KO models |
| ATG7 | E1-like enzyme required for ATG8/LC3 conjugation | Essential for mitophagy; conditional KO models |
| MAP1LC3B (LC3B) | Autophagosomal marker that binds mitophagy receptors | Fluorescent tagging for imaging mitophagy |
| SQSTM1 (p62) | Ubiquitin-binding autophagy receptor that delivers ubiquitinated mitochondria | KO and overexpression models for cargo recognition |
| OPTN | Autophagy receptor involved in ubiquitin-dependent mitophagy | Mutations linked to neurodegeneration; KO models |
| TBK1 | Kinase that phosphorylates autophagy receptors and regulates mitophagy | Disease-associated mutations; point-mutation models |
| MFN1/MFN2 | Mitofusins that regulate mitochondrial fusion and influence mitophagy | KO models show altered mitochondrial dynamics and mitophagy |
| DNM1L (DRP1) | GTPase that mediates mitochondrial fission, facilitating mitophagy | KO and point-mutation models for fission-mitophagy coupling |
| TFEB | Transcription factor that promotes lysosomal and autophagy gene expression | Overexpression models enhance mitophagy capacity |
| MTOR | Kinase that suppresses autophagy initiation under nutrient-rich conditions | Pharmacological and genetic regulation studies |
| AMPK | Energy sensor that activates ULK1 and promotes mitophagy | KO and point-mutation models for metabolic regulation |
How Is autophagy of mitochondrion Regulated?
Mitophagy is regulated by nutrient and energy signaling. Under nutrient-rich conditions, mTOR suppresses autophagy initiation, whereas energy stress activates AMPK, which promotes ULK1 activity and mitophagy. Transcriptional control adds another layer: TFEB and related factors upregulate lysosomal and autophagy genes to increase mitophagic capacity. At the mitochondrial surface, PINK1-Parkin signaling is controlled by mitochondrial membrane potential, and receptor-mediated mitophagy is regulated by phosphorylation and hypoxia-inducible expression of BNIP3 and BNIP3L/NIX. These regulatory inputs allow GO:0000422 to respond dynamically to changing cellular conditions.
autophagy of mitochondrion and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PINK1 | Early-onset Parkinson's disease | Knockout and point-mutation cell models; neuronal differentiation |
| PRKN | Parkinson's disease | Knockout and knock-in models; mitochondrial function assays |
| BNIP3 | Hypoxia-related cardiac and metabolic disease | Overexpression and knockout models under hypoxia |
| FUNDC1 | Cardiovascular and hypoxic stress responses | Point-mutation models of phosphorylation sites |
| SQSTM1 | Neurodegeneration and inflammatory signaling | Knockout models with mitochondrial DNA readouts |
Mitophagy in Parkinson's disease and neurodegeneration
Loss-of-function mutations in PINK1 and PRKN cause early-onset Parkinson's disease, and defective mitophagy is thought to contribute to dopaminergic neuron loss. PINK1 and Parkin cooperate to maintain mitochondrial fidelity, and their failure allows damaged mitochondria to accumulate in neurons. More broadly, impaired mitophagy is implicated in ageing and neurodegenerative processes. These findings make GO:0000422 a central pathway for neurodegeneration research.
Mitophagy in cardiovascular disease
In the heart, mitophagy is required for cardiomyocyte homeostasis, and its dysregulation contributes to ischemia-reperfusion injury, heart failure and other cardiovascular pathologies. Molecular mechanisms involving PINK1-Parkin and receptor-mediated pathways have been linked to cardioprotection and disease progression. Targeting mitophagy is therefore considered a therapeutic strategy in cardiovascular disease.
Mitophagy in liver disease
Mitophagy plays important roles in hepatic metabolism and in the pathogenesis of liver diseases, including fatty liver disease and ischemia-reperfusion injury. Altered mitophagy can affect hepatocyte survival, lipid metabolism and inflammation. Experimental models of liver disease are used to test whether restoring mitophagy is beneficial.
Mitophagy, mitochondrial DNA and inflammation
Mitochondrial DNA is normally degraded during mitophagy, and failure to eliminate it can trigger inflammatory responses. The distribution and elimination of mitochondrial DNA are therefore closely tied to mitophagic flux. This connection links GO:0000422 to innate immune signaling and to diseases involving chronic inflammation.
From autophagy of mitochondrion-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a gene required for mitophagy? | CRISPR knockout cell line with mitophagy flux assay |
| Does a disease variant impair mitophagy? | Point-mutation knock-in of the variant |
| Where does a protein localize during mitophagy? | Endogenous fluorescent or epitope tagged knock-in |
| Does overexpression enhance mitochondrial clearance? | Doxycycline-inducible overexpression cell line |
| Which genes modify mitophagy in a genome-wide screen? | CRISPR library screening with mitophagy reporter |
| How does a drug affect mitophagy? | Wild-type reporter cell line with small-molecule treatment |
How to Study the autophagy of mitochondrion Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Mito-Keima imaging | Delivery of mitochondria to acidic compartments | Live-cell mitophagy flux measurement |
| Mito-QC reporter | Tandem fluorescent mitophagy index | High-content screening and tissue analysis |
| Western blot | LC3 lipidation and mitochondrial protein turnover | Biochemical validation of mitophagy |
| Proteomics | Mitochondrial protein abundance and ubiquitination | Pathway mechanism studies |
| RNA-seq | Transcriptional regulation of mitophagy genes | Stress and disease model profiling |
| CRISPR library screening | Genes that modify mitophagy | Unbiased discovery of regulators |
| Mitochondrial DNA quantification | Mitochondrial genome elimination and release | Inflammation and quality-control studies |
| Seahorse respiration | Mitochondrial oxidative function | Functional consequence of mitophagy modulation |
Imaging-based mitophagy reporters
Fluorescent reporters such as mito-Keima and mito-QC allow ratiometric or tandem measurement of mitochondrial delivery to acidic compartments, providing spatial and quantitative readouts of GO:0000422. These reporters are widely used in live-cell imaging and in high-content screening.
Biochemical and proteomic assays
Western blotting for mitochondrial proteins, LC3 lipidation and receptor turnover provides biochemical evidence of mitophagic flux. Proteomics can quantify changes in mitochondrial protein abundance and identify ubiquitinated outer-membrane proteins during PINK1-Parkin-dependent mitophagy.
Transcriptomic and CRISPR screening approaches
RNA-seq identifies transcriptional programs, including TFEB targets and hypoxia-induced receptors, that regulate mitophagy. CRISPR knockout and activation screens with mitophagy reporters enable unbiased discovery of genes that modify GO:0000422.
Mitochondrial DNA and functional readouts
Quantification of mitochondrial DNA copy number and release can reveal defects in mitochondrial elimination and inflammatory consequences. Functional assays such as Seahorse respiration and ROS measurement connect mitophagy status to mitochondrial performance.
How CRISPR Can Be Used to Study GO:0000422 autophagy of mitochondrion
Knockout
CRISPR knockout cell lines are used to test whether a candidate gene is required for GO:0000422. For example, knocking out PINK1, PRKN, ATG5 or ATG7 impairs mitophagy and provides a clean genetic background for rescue experiments. Knockout models are also used in genome-wide screens to identify new mitophagy regulators.
Point Mutation
Point-mutation knock-in models allow researchers to test disease-associated variants, such as PINK1 or PRKN mutations linked to Parkinson's disease, or phosphorylation-site mutations in FUNDC1 and BNIP3. These models distinguish loss-of-function, gain-of-function and separation-of-function effects on mitophagy.
Knock-in
Tagged knock-in of endogenous genes, such as LC3B or mitophagy receptors, enables visualization and immunoprecipitation of mitophagy machinery at native expression levels. Knock-in reporters avoid artifacts caused by overexpression and are valuable for imaging and proteomic studies.
Overexpression
Overexpression models are used to test whether increasing a gene product enhances mitochondrial clearance or protects against stress. Inducible overexpression of TFEB, BNIP3 or Parkin can boost mitophagy and is useful for gain-of-function studies and drug-response assays.
How EDITGENE Supports autophagy of mitochondrion Research
Researchers studying autophagy of mitochondrion-related genes often need to determine whether a candidate gene is causally involved in mitochondrial clearance, how a disease variant alters protein function, or where a protein acts within the mitophagy pathway. EDITGENE provides CRISPR-based cell model services that support each of these questions with reproducible, publication-ready reagents.
Contact EDITGENE today to design your custom CRISPR model for autophagy of mitochondrion research.
Frequently Asked Questions About autophagy of mitochondrion
What is GO:0000422 autophagy of mitochondrion?
GO:0000422 is the Gene Ontology biological_process term for the autophagic process in which mitochondria are delivered to a vacuole or lysosome and degraded in response to changing cellular conditions; it is commonly called mitophagy.
What genes are involved in autophagy of mitochondrion?
Key genes include PINK1, PRKN, BNIP3, BNIP3L/NIX, FUNDC1, FKBP8, ULK1, ATG5, ATG7, MAP1LC3B, SQSTM1, OPTN, TBK1, MFN1/MFN2, DNM1L, TFEB, MTOR and AMPK.
What is the difference between mitophagy and autophagy?
Mitophagy is a selective form of autophagy in which the cargo is specifically mitochondria, whereas general autophagy degrades a broader range of cytoplasmic material.
How is mitophagy regulated?
Mitophagy is regulated by nutrient and energy signaling through mTOR and AMPK, by transcriptional programs involving TFEB, and by mitochondrial membrane potential and receptor phosphorylation.
Which diseases are linked to defective mitophagy?
Defective mitophagy is linked to Parkinson's disease, cardiovascular disease, liver disease and ageing-related phenotypes.
What is the PINK1-Parkin pathway?
The PINK1-Parkin pathway is a ubiquitin-dependent mitophagy route in which PINK1 accumulates on depolarized mitochondria and recruits the Parkin E3 ligase to ubiquitinate outer-membrane proteins.
How do researchers measure mitophagy?
Common methods include mito-Keima and mito-QC imaging, LC3 western blotting, proteomics, RNA-seq, CRISPR screens and mitochondrial DNA quantification.
Can CRISPR be used to study autophagy of mitochondrion?
Yes, CRISPR knockout, point-mutation, knock-in and overexpression models are widely used to dissect mitophagy gene function and to build screening platforms.
What happens to mitochondrial DNA during mitophagy?
Mitochondrial DNA is delivered to the degradative compartment and eliminated during mitophagy, and failure of this process can trigger inflammatory signaling.
Why is mitophagy important for cell survival?
Mitophagy removes damaged mitochondria that would otherwise produce excess reactive oxygen species and trigger cell death, thereby supporting cellular homeostasis.
Conclusion
GO:0000422 autophagy of mitochondrion is a selective autophagic process that removes damaged or surplus mitochondria and is essential for mitochondrial quality control, metabolic adaptation and cell survival. Its molecular basis spans PINK1-Parkin ubiquitin signaling, receptor-mediated cargo recognition and core autophagy machinery, with regulation by mTOR, AMPK and transcription factors. Defects in mitophagy are implicated in Parkinson's disease, cardiovascular disease, liver disease and ageing, making the pathway a major therapeutic and research target. CRISPR-based cell models provide a powerful route to dissect these mechanisms and to test disease variants and candidate drugs.
References
- 1. Lu Y et al.. 2023. Cellular mitophagy: Mechanism, roles in diseases and small molecule pharmacological regulation.. Theranostics 13(2):736-766 PMID: 36632220
- 2. Picca A et al.. 2023. Mitophagy in human health, ageing and disease.. Nat Metab 5(12):2047-2061 PMID: 38036770
- 3. Onishi M et al.. 2021. Molecular mechanisms and physiological functions of mitophagy.. EMBO J 40(3):e104705 PMID: 33438778
- 4. Wang S et al.. 2023. The mitophagy pathway and its implications in human diseases.. Signal Transduct Target Ther 8(1):304 PMID: 37582956
- 5. Pickrell AM et al.. 2015. The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson's disease.. Neuron 85(2):257-73 PMID: 25611507
- 6. Ajoolabady A et al.. 2022. Mitophagy in cardiovascular diseases: molecular mechanisms, pathogenesis, and treatment.. Trends Mol Med 28(10):836-849 PMID: 35879138
- 7. Yan C et al.. 2019. Mitochondrial DNA: Distribution, Mutations, and Elimination.. Cells 8(4) PMID: 31027297
- 8. Ma X et al.. 2020. Role and Mechanisms of Mitophagy in Liver Diseases.. Cells 9(4) PMID: 32244304
